Navigation Links
Persistent AF Patient Treated with HeartLight™ Endoscopic Ablation System in Live Case at Venice Arrhythmias 2011
Date:10/12/2011

for the first time, visually direct the application of laser energy to achieve durable pulmonary vein isolation.

The HeartLight Endoscopic Ablation System received CE Mark in 2009 for the treatment of atrial fibrillation, and is commercially available at leading institutions throughout Europe. The device is investigational in the U.S., with a pivotal study expected to commence in 2011. CardioFocus is headquartered in Marlborough, MA, USA.  For more information on the company and its technology, please visit www.CardioFocus.com.

The scientific information discussed in this news release is preliminary and investigative. The CardioFocus HeartLight Endoscopic Ablation System is not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the system. Only FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Healthcare professionals should refer to/rely upon FDA-approved labeling for the products, and not the information discussed in this news release.Company Contact:

Media Contact:Anjie Roldan

Lisa CookVice President Finance

(646) 536-7012(508) 658-7237

lcook@theruthgroup.com  aroldan@cardiofocus.com
'/>"/>

SOURCE CardioFocus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Durable Medical Equipment Community Supports Tough Anti-Fraud Measures, Corrects Persistent Myths
2. STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
3. FDA Approves New Device for Adults with Severe and Persistent Asthma
4. Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
5. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
6. Study Analyzed SYMBICORT(R) in Children with Persistent Asthma
7. NeuroQuant®, CorTechs Labs FDA-Cleared System for Quantifying Regional Brain Atrophy from MRIs, Used to Identify Patients at Highest Risk for Developing Dementia
8. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
9. Omeros Announces First Patients Treated in Phase 3 Clinical Program Evaluating OMS302
10. Herbal Supplements May Cause Dangerous Drug Interactions in Orthopaedic Surgery Patients
11. NCPA Digest Finds Independent Community Pharmacies Reducing Health Costs Through Generic Drug Use, Patient Counseling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... EDISON, N.J. , March 5, 2015  ContraVir ... company focused on the development and commercialization of targeted ... the 27 th Annual ROTH Conference, to be ... CA. James Sapirstein , ... Company,s business during his live presentation and will be ...
(Date:3/5/2015)... March 5, 2015 According to ... by Product (Systems and Disposables), by Type (Invasive, Minimally ... Home and Ambulatory Sites) - Analysis & Global Forecast ... is expected to reach $1,107.4 Million by 2019 from ... at a CAGR of 4.5% during the forecast period. ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Ascendis Pharma to Present at ENDO 2015 2
... Worldwide, MENLO PARK, Calif., Nov. 15 ... global Phase III clinical program to,evaluate the efficacy ... program, which includes the COGENT-1 and COGENT-2 trials, ... in the United States, Canada,Europe and South America. ...
... Calif., Nov. 15 BiPar,Sciences, Inc., a privately ... it has initiated a Phase 2 study of ... breast,cancer that do not express the estrogen, progesterone ... Phase 2 trial in this indication-which,represents a major ...
Cached Medicine Technology:Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 3
(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... 2015 On March 2, 2015, NBC ... on the Rise, Plastic Surgeons Say,” that comments on ... for Aesthetic Plastic Surgery and the American ... a year-over-year doubling of surgical butt augmentations performed in ... the article, this increase can be attributed to the ...
(Date:3/5/2015)... HMP Communications Holdings , ... education, announced today its acquisition of the ... medical conference designed for health care providers dedicated ... amputation due to vascular disorders. The 5-year-old ... publications and CME activities across therapeutic fields such ...
(Date:3/5/2015)... Venice, FL (PRWEB) March 05, 2015 ... their 15th annual listing of “Pros to Know” in ... announce that two members of MEBC’s leadership team were ... Rhodes were nominated and received this award due to ... use of innovative methods for meeting and resolving client ...
(Date:3/5/2015)... 2015 Leading nutritional supplement provider ... Sports Festival and Arnold Fitness EXPO in ... will host a display booth featuring free samples of ... its highly-popular, class-leading fat burner Synedrex. The company will ... that utilize its top-of-the-line supplements and miniature action figures ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2
... test by using EEG can predict whether a person ... by Leslie S. Prichep of the New York University School ... 44 patients and followed these people for a decade. The ... would develop dementia. ,Dementia is a brain disorder that causes ...
... research from the National Institute of Diabetes and Digestive and ... shown stabalisation of annual increases from 5 to 10 ... there is still a dramatic racial disparity. , ... than 1 percent since 1999, compared to an average 5 ...
... cancer vaccine trial against Melanoma which is a type ... vaccine developed by Antigenics.// The vaccine trial of Oncophage ... the required statistically significance results compared to prolongation in ... any better results compared to other cancer treatments. ...
... a near-pandemic condition that threatens millions with loss of ... atherosclerotic plaque in the arteries outside your heart.// Stem ... blood vessels and grow new ones thus restoring blood ... Ltd, a private, multinational company focuses on using stem ...
... inflammation according to scientists. Inflammation has a role to ... cardiovascular disease, diabetes, obesity, Alzheimer’s besides infections//. , ... said: “Practically every common disease involves an inflammation component,” ... Research (SFBR) in San Antonio., ,“So the discovery ...
... following ace cricketer Sachin Tendulkar's and several other players complaining ... the sports arena//. ,Tennis elbow, or lateral epicondylitis ... where the outer part of the elbow becomes painful and ... or a direct bang. The problem occurs following overuse of ...
Cached Medicine News:Health News:US Kidney Failure Rates show Stabilization After 20-Year Climb 2Health News:Tennis elbow not new among cricketers, say experts 2
... inhalers., ,ACE ensures prompt, effective delivery ... versatile design allows it to be used ... an endotracheal airway or resuscitation bag and ... be used in conjunction with an incentive ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
... four models in proven halogen technology and ... find the right solution for every application: ... combination of two or three mobile lamps ... an on/off switch on the lamp housing, ...
Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
Medicine Products: